Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 308-114-5 | CAS number: 97862-65-2
Endpoint summary
Administrative data
Description of key information
The lowest acute oral LD50 obtained for the test item was found to be 526 mg/kg bw for male and female rats.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1982-09-20 to 1982-10-06
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted 1981
- Deviations:
- no
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Code No.: TK10363
- Batch No.: 42.29
- Physical state: Powder - Species:
- rat
- Strain:
- other: Tif:RAIF (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: CIBA-GEIGY LTD. Tierfarm, 4334 Sisseln, Switzerland
- Age at study initiation: 7 -8 weeks
- Weight at study initiation: 151 - 211 g
- Housing: Animals were caged in groups of 5 in Macrolon cages type 3 with standardised soft wood bedding (Societe Parisienne des sciures, Pantin).
- Diet: Rat food, NAPAG No. 890, NAPAG AG Gossau, Switzerland, provided ad libitum
- Water: Drinking water, provided ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/-3
- Humidity (%): 55 +/- 15
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- other: Distilled water containing 0.5 % carboxymethylcellulose and 0.1 % polysorbate 80
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 25, 50, 100 mg/mL vehicle
- Amount of vehicle: 10 mL - Doses:
- 250, 500, 1000 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology - Statistics:
- From the body weights the group means and their standard deviations were calculated. Where feasable, the LD50 including the 95% confidence limit were computed by the logit method (J. Berkson, J.Am. Stat. Ass. 39. 357-65, 1944).
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 525 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 417 - < 688
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 525 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 345 - < 871
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 525 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 345 - < 871
- Mortality:
- Males
250 mg/kg bw: no mortalities
500 mg/kg bw: 2 mortalities, both 2 h after treatment
1000 mg/kg bw: 5 mortalities, one at 1h after treatment, four at 2 h after treatment.
Females
250 mg/kg bw: no mortalities
500 mg/kg bw: 2 mortalities, both 2 h after treatment
1000 mg/kg bw: 5 mortalities, one at 1h after treatment, four at 2 h after treatment. - Clinical signs:
- other: No specific symptoms were seen, except for transient clonic- tonic muscle spasms in the animals treated with 500 mg/kg.
- Gross pathology:
- No compound related gross organ changes were observed. However, due to the colour of the test item, a red discoloration of the whole body was observed during 9 days in the animals treated with 250 mg/kg and during the whole observation period in the animals treated with 500 mg/kg.
- Other findings:
- The surviving animals recovered within 10 days.
- Interpretation of results:
- Category 4 based on GHS criteria
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 526 mg/kg bw
- Quality of whole database:
- Guideline compliant study.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
Key study
In an oral toxicity study (Ciba-Geigy, 1982) conducted according to OECD 401, the test item was administered to five male and female rats per sex per dose via gavage followed by a 14 -day observation period. The dose levels were as follows: 250, 500 and 1000 mg/kg bw. After the administration, the following mortalities were observed:
Males
250 mg/kg bw: no mortalities 500 mg/kg bw: 2 mortalities, both 2 h after treatment 1000 mg/kg bw: 5 mortalities, one at 1h after treatment, four at 2 h after treatment.
Females
250 mg/kg bw: no mortalities 500 mg/kg bw: 2 mortalities, both 2 h after treatment 1000 mg/kg bw: 5 mortalities, one at 1h after treatment, four at 2 h after treatment.
No compound related changes in body weight and no specific symptoms were observed, except for transient clonic- tonic muscle spasms in the animals treated with 500 mg/kg. A red discoloration of the whole body was observed during 9 days in the animals treated with 250 mg/kg and during the whole observation period in the animals treated with 500 mg/kg bw. The LD50 values were determined to be 525 mg/kg bw for male and female rats and a combined LD50 of 526 mg/kg bw was determined for both sexes.
Supporting studies
The three independent supporting studies conducted with male and female rats are of limited reliability, In these studies the test substance is of low acute toxicity and the respective LD50 values were above the value determined in the key study. In this studies the LD50 values were determined to be 1800 mg/kg bw (Ciba-Geigy Ltd..1972), >= 4000 mg/kg bw (Unknown.Acute toxicity: oral_rat.1969) and >= 5000 mg/kg bw ( Unknown. 1970).
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable forclassification purposes under Regulation (EC) No 1272/2008. Based on the result obtained in the key acute oral toxicity study (LD50, rat = 526 mg/kg bw) the test item has to be classified in acute toxicity category 4 (H302: Harmful if swallowed) according to Regulation (EC) No 1272/2008 (GHS), as amended for the sixth time in Regulation EC 944/2013
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
